进展期-话题@MedSci

#进展期#

74篇内容 | 897人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1814005, encodeId=471a181400555, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=ASCO 2014：进展期卵巢癌：新辅助化疗创伤低于标准治疗, objectType=article, longId=36096, objectId=bd693609667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd693609667, replyNumber=0, likeNumber=36, createdTime=2014-06-19, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd693609667, moduleTitle=ASCO 2014：进展期卵巢癌：新辅助化疗创伤低于标准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd693609667)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1814016, encodeId=b4c81814016b7, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=CCC：一线靶向治疗进展期结直肠癌，抗EGFR优于抗VEGF单抗（ Meta分析）, objectType=article, longId=45297, objectId=edad4529e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edad4529e9b, replyNumber=0, likeNumber=44, createdTime=2015-07-01, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edad4529e9b, moduleTitle=CCC：一线靶向治疗进展期结直肠癌，抗EGFR优于抗VEGF单抗（ Meta分析）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edad4529e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1814010, encodeId=965e1814010df, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=CSCO 2014：进展期胃癌的二线治疗进展, objectType=article, longId=40526, objectId=ea104052617, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea104052617, replyNumber=0, likeNumber=41, createdTime=2014-11-25, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea104052617, moduleTitle=CSCO 2014：进展期胃癌的二线治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea104052617)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1814001, encodeId=eb4a18140018a, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=ASCO 2014：亚洲进展期肝癌患者口服c-Met抑制剂MSC2156119J单药与索拉非尼比较的Ib/II期试验, objectType=article, longId=35648, objectId=35c7356487a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35c7356487a, replyNumber=0, likeNumber=35, createdTime=2015-03-21, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35c7356487a, moduleTitle=ASCO 2014：亚洲进展期肝癌患者口服c-Met抑制剂MSC2156119J单药与索拉非尼比较的Ib/II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35c7356487a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1814009, encodeId=e13318140099c, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=CSCO 2014：局部进展期胃癌放化疗的是与非, objectType=article, longId=40475, objectId=82b3404e559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82b3404e559, replyNumber=0, likeNumber=38, createdTime=2014-12-17, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82b3404e559, moduleTitle=CSCO 2014：局部进展期胃癌放化疗的是与非, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82b3404e559)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1814004, encodeId=6f8f181400492, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=ASCO 2014：Bev+DOF可降低局部进展期胃癌的TN分期, objectType=article, longId=35657, objectId=c5db3565eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5db3565eb6, replyNumber=0, likeNumber=40, createdTime=2014-11-16, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5db3565eb6, moduleTitle=ASCO 2014：Bev+DOF可降低局部进展期胃癌的TN分期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5db3565eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813999, encodeId=40081813999ed, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=ASCO2013：国立台湾大学Ann-Lii Cheng将开展Regorafenib治疗进展期肝细胞癌3期试验, objectType=article, longId=19004, objectId=56441900446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56441900446, replyNumber=0, likeNumber=45, createdTime=2013-12-01, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56441900446, moduleTitle=ASCO2013：国立台湾大学Ann-Lii Cheng将开展Regorafenib治疗进展期肝细胞癌3期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56441900446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813997, encodeId=6de3181399e28, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=J CANCER RES CLIN：部分进展期肝癌仍可手术, objectType=article, longId=11975, objectId=272b119e548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=272b119e548, replyNumber=0, likeNumber=49, createdTime=2012-12-31, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=272b119e548, moduleTitle=J CANCER RES CLIN：部分进展期肝癌仍可手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=272b119e548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813994, encodeId=f57c181399416, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=进展期食管胃交界腺癌临床病理分析, objectType=article, longId=5956, objectId=f9c35956ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9c35956ef, replyNumber=0, likeNumber=38, createdTime=2012-07-08, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9c35956ef, moduleTitle=进展期食管胃交界腺癌临床病理分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9c35956ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813998, encodeId=5f421813998ba, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案, objectType=article, longId=12101, objectId=dd1912101f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1912101f8, replyNumber=0, likeNumber=61, createdTime=2013-08-04, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1912101f8, moduleTitle=JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1912101f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813996, encodeId=321c181399671, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=替吉奥联合奥沙利铂或顺铂对进展期胃癌近期疗效好, objectType=article, longId=7476, objectId=b7a2e476fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7a2e476fe, replyNumber=0, likeNumber=49, createdTime=2013-01-12, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7a2e476fe, moduleTitle=替吉奥联合奥沙利铂或顺铂对进展期胃癌近期疗效好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7a2e476fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813995, encodeId=027c1813995db, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=ASCO:T-DM1治疗进展期HER2阳性乳腺癌优于卡培他滨+拉帕替尼, objectType=article, longId=6777, objectId=f36c6e7786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f36c6e7786, replyNumber=0, likeNumber=58, createdTime=2013-05-07, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f36c6e7786, moduleTitle=ASCO:T-DM1治疗进展期HER2阳性乳腺癌优于卡培他滨+拉帕替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f36c6e7786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813993, encodeId=72901813993d9, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=进展期胃癌治疗的观点, objectType=article, longId=3303, objectId=068d3303f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=068d3303f2, replyNumber=0, likeNumber=51, createdTime=2012-05-06, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=068d3303f2, moduleTitle=进展期胃癌治疗的观点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=068d3303f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813992, encodeId=a865181399275, content=<a href='/topic/show?id=edff943e88a' target=_blank style='color:#2F92EE;'>#进展期#</a>, objectTitle=小肠或胰腺来源的进展期胃肠胰腺神经内分泌癌的治疗策略, objectType=article, longId=2705, objectId=c7ca2e05bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ca2e05bc, replyNumber=0, likeNumber=63, createdTime=2011-08-03, rootId=0, userName=licz0423, userId=5fca128, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ca2e05bc, moduleTitle=小肠或胰腺来源的进展期胃肠胰腺神经内分泌癌的治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7ca2e05bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

进展期

2020-05-29

licz0423 (审核中...)

前往app查看评论内容

#进展期#

ASCO 2014：进展期卵巢癌：新辅助化疗创伤低于标准治疗

2014-06-19

licz0423 (审核中...)

前往app查看评论内容

#进展期#

CCC：一线靶向治疗进展期结直肠癌，抗EGFR优于抗VEGF单抗（ Meta分析）

2015-07-01

licz0423 (审核中...)

前往app查看评论内容

#进展期#

CSCO 2014：进展期胃癌的二线治疗进展

2014-11-25

licz0423 (审核中...)

前往app查看评论内容

#进展期#

ASCO 2014：亚洲进展期肝癌患者口服c-Met抑制剂MSC2156119J单药与索拉非尼比较的Ib/II期试验

2015-03-21

licz0423 (审核中...)

前往app查看评论内容

#进展期#

CSCO 2014：局部进展期胃癌放化疗的是与非

2014-12-17

licz0423 (审核中...)

前往app查看评论内容

#进展期#

ASCO 2014：Bev+DOF可降低局部进展期胃癌的TN分期

2014-11-16

licz0423 (审核中...)

前往app查看评论内容

#进展期#

ASCO2013：国立台湾大学Ann-Lii Cheng将开展Regorafenib治疗进展期肝细胞癌3期试验

2013-12-01

licz0423 (审核中...)

前往app查看评论内容

#进展期#

J CANCER RES CLIN：部分进展期肝癌仍可手术

2012-12-31

licz0423 (审核中...)

前往app查看评论内容

#进展期#

进展期食管胃交界腺癌临床病理分析

2012-07-08

licz0423 (审核中...)

前往app查看评论内容

#进展期#

JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案

2013-08-04

licz0423 (审核中...)

前往app查看评论内容

#进展期#

替吉奥联合奥沙利铂或顺铂对进展期胃癌近期疗效好

2013-01-12

licz0423 (审核中...)

前往app查看评论内容

#进展期#

ASCO:T-DM1治疗进展期HER2阳性乳腺癌优于卡培他滨+拉帕替尼

2013-05-07

licz0423 (审核中...)

前往app查看评论内容

#进展期#

进展期胃癌治疗的观点

2012-05-06

licz0423 (审核中...)

前往app查看评论内容

#进展期#

小肠或胰腺来源的进展期胃肠胰腺神经内分泌癌的治疗策略

2011-08-03

科室
- - 订阅+
  - 更多科室
工具
服务